Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin

Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Pintu Prajapati, Pooja Patel, Dhrumi Naik, Anzarul Haque, Shailesh Shah
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	SpringerOpen 2024-11-01
Sarja:	Future Journal of Pharmaceutical Sciences
Aiheet:	Metformin hydrochloride Teneligliptin hydrobromide hydrate Pioglitazone hydrochloride Analytical quality by design Response surface modeling
Linkit:	https://doi.org/10.1186/s43094-024-00746-7
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!